Your session is about to expire
← Back to Search
Sensor Skin for Liver Cirrhosis
N/A
Recruiting
Led By Jasmohan Bajaj, MD
Research Sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 days
Awards & highlights
Study Summary
This trial found that measuring inflammation over time using a skin device was more predictive of disease outcomes than a single blood draw.
Eligible Conditions
- Liver Cirrhosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Therapeutic procedure
Secondary outcome measures
Interleukin-6
Interleukin-6
Linkage of inflammatory markers with MELD score
+1 moreTrial Design
3Treatment groups
Experimental Treatment
Group I: Outpatients with cirrhosisExperimental Treatment1 Intervention
Outpatients with cirrhosis will receive the sensors
Group II: Inpatients with cirrhosisExperimental Treatment1 Intervention
Inpatients with cirrhosis will receive the sensors
Group III: Healthy controlsExperimental Treatment1 Intervention
Healthy controls will receive the sensors
Find a Location
Who is running the clinical trial?
Hunter Holmes Mcguire Veteran Affairs Medical CenterLead Sponsor
35 Previous Clinical Trials
21,491 Total Patients Enrolled
8 Trials studying Liver Cirrhosis
345 Patients Enrolled for Liver Cirrhosis
Jasmohan Bajaj, MDPrincipal InvestigatorHunter Holmes McGuire VAMC
3 Previous Clinical Trials
112 Total Patients Enrolled
2 Trials studying Liver Cirrhosis
64 Patients Enrolled for Liver Cirrhosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a long-term health condition.You have a disease that requires medication to suppress your immune system, such as inflammatory bowel disease.You have severe liver problems that are causing symptoms such as fluid buildup in the abdomen, confusion, bleeding from enlarged veins in the esophagus, or difficulty breathing due to liver-related lung issues.It's not clear if you have cirrhosis or not.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy controls
- Group 2: Outpatients with cirrhosis
- Group 3: Inpatients with cirrhosis
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger